A two-arm chemoprevention trial in familial adenomatous polyposis coli patients using the purified free fatty acid, eicosapentaenoic acid.

Trial Profile

A two-arm chemoprevention trial in familial adenomatous polyposis coli patients using the purified free fatty acid, eicosapentaenoic acid.

Completed
Phase of Trial: Phase II/III

Latest Information Update: 20 Oct 2014

At a glance

  • Drugs Eicosapentaenoic acid (Primary)
  • Indications Colorectal cancer; Familial adenomatous polyposis
  • Focus Therapeutic Use
  • Sponsors SLA Pharma
  • Most Recent Events

    • 01 May 2010 Results presented at 2010 Digestive Disease Week.
    • 26 Mar 2010 Results published in Gut.
    • 16 Oct 2008 Status changed from active, no longer recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top